Filing Flows › Emmaus Life Sciences (EMMA) › Endari US revenue
Emmaus Life Sciences (EMMA) Endari US revenue by quarter
Emmaus Life Sciences' Endari US revenue was $6.0M in Q2 2026 (second quarter 2026), +336% from Q1 2026. Over the last 3 quarters it ranged from $1.4M (Q1 2026) to $6.0M (Q2 2026).
| Quarter | Endari US revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $6.0M | +336% | — |
| Q1 2026 | $1.4M | -53% | — |
| Q4 2024 | $2.9M | — | — |
Q2 2026 at a glance
Emmaus Life Sciences, Q2 2026: revenue $6.3M (+124% year over year), operating margin 60.0%, net earnings $1.3M, operating cash flow $1.7M. The chart follows the revenue to costs, profit and cash.
Questions
What is Emmaus Life Sciences' Endari US revenue?
Emmaus Life Sciences' Endari US revenue was $6.0M in Q2 2026 (second quarter 2026), +336% from Q1 2026.
How has Emmaus Life Sciences' Endari US revenue changed?
Over the last 3 quarters it ranged from $1.4M (Q1 2026) to $6.0M (Q2 2026).